BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $661,092 | -7.8% | 17,517 | +11.3% | 0.05% | -12.5% |
| Q2 2023 | $717,160 | +26.7% | 15,741 | +12.8% | 0.06% | +5.7% |
| Q1 2023 | $565,974 | -16.5% | 13,954 | +4.9% | 0.05% | -24.3% |
| Q4 2022 | $678,156 | +2.9% | 13,305 | +8.7% | 0.07% | -10.3% |
| Q3 2022 | $659,000 | +0.3% | 12,242 | +19.6% | 0.08% | -7.1% |
| Q2 2022 | $657,000 | -12.5% | 10,233 | +5.6% | 0.08% | 0.0% |
| Q1 2022 | $751,000 | +1.5% | 9,687 | +12.4% | 0.08% | -3.4% |
| Q4 2021 | $740,000 | +45.1% | 8,617 | +35.9% | 0.09% | +13.0% |
| Q3 2021 | $510,000 | -42.8% | 6,340 | -42.9% | 0.08% | +2.7% |
| Q2 2021 | $892,000 | +117.0% | 11,108 | +116.7% | 0.08% | +4.2% |
| Q1 2021 | $411,000 | 0.0% | 5,127 | 0.0% | 0.07% | 0.0% |
| Q4 2020 | $411,000 | +20.9% | 5,127 | +21.4% | 0.07% | -1.4% |
| Q3 2020 | $340,000 | +18.1% | 4,222 | +26.4% | 0.07% | +87.2% |
| Q2 2020 | $288,000 | +22.0% | 3,341 | +14.7% | 0.04% | -46.6% |
| Q1 2020 | $236,000 | +10.8% | 2,912 | -14.1% | 0.07% | 0.0% |
| Q3 2017 | $213,000 | +1836.4% | 3,389 | +1379.9% | 0.07% | +942.9% |
| Q4 2016 | $11,000 | – | 229 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |